Mamesaya, N., Kenmotsu, H., & Takahashi, T. (2017). Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab. Invest New Drugs.
Citação norma ChicagoMamesaya, Nobuaki, Hirotsugu Kenmotsu, and Toshiaki Takahashi. "Successful Osimertinib Rechallenge in a Patient With Advanced Non-small Cell Lung Cancer Following Osimertinib-induced Interstitial Lung Disease After Treatment With Nivolumab." Invest New Drugs 2017.
Citação norma MLAMamesaya, Nobuaki, Hirotsugu Kenmotsu, and Toshiaki Takahashi. "Successful Osimertinib Rechallenge in a Patient With Advanced Non-small Cell Lung Cancer Following Osimertinib-induced Interstitial Lung Disease After Treatment With Nivolumab." Invest New Drugs 2017.